Treatment data and technical process challenges for practical big data efforts in radiation oncology by Mayo, CS et al.
This is the author manuscript accepted for publication and has undergone full peer review but has 
not been through the copyediting, typesetting, pagination and proofreading process, which may 
lead to differences between this version and the Version of Record. Please cite this article as doi: 
10.1002/mp.13114 
This article is protected by copyright. All rights reserved 
 




















































1)University of Michigan, Ann Arbor, MI,2) University of Washington, Seattle, WA,  3) Johns 
Hopkins University, Baltimore, MD , 4) Virginia Commonwealth University, Richmond VA, 5) 
Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental 
Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands, 6) Mayo Clinic, 
Jacksonville, FL,6) University of Washington, Seattle, WA,7) University of Pennsylvania, 
Philadelphia, PA,8) Ohio State University, Columbus, OH, 9) Memorial Sloan Kettering Cancer 
Center, New York, NY,10) University of California at San Francisco, San Francisco CA, 11) 
University of Alabama at Birmingham, Birmingham, AL,12) Harvard Medical School, Boston, MA, 


























Corresponding Author – Charles Mayo, University of Michigan, Ann Arbor, MI  
cmayo@med.umich.edu 
 
Conflicts of Interest – There are no conflicts of interest 
 
Acknowledgements 
















This article is protected by copyright. All rights reserved 
 1 
Received Date:  2 
Revised Date:  3 
Accepted Date:  4 
Article Type: Special Issue Paper 5 




















































1)University of Michigan, Ann Arbor, MI,2) University of Washington, Seattle, WA,  3) Johns 14 
Hopkins University, Baltimore, MD , 4) Virginia Commonwealth University, Richmond VA, 5) 15 
Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental 16 
Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands, 6) Mayo Clinic, 17 
Jacksonville, FL,6) University of Washington, Seattle, WA,7) University of Pennsylvania, 18 
Philadelphia, PA,8) Ohio State University, Columbus, OH, 9) Memorial Sloan Kettering Cancer 19 
Center, New York, NY,10) University of California at San Francisco, San Francisco CA, 11) 20 
University of Alabama at Birmingham, Birmingham, AL,12) Harvard Medical School, Boston, MA, 21 
13) MD Anderson Cancer Center, Houston, TX, University of California at Los Angeles, Los 22 

























Corresponding Author – Charles Mayo, University of Michigan, Ann Arbor, MI  32 
cmayo@med.umich.edu 33 
 34 
Conflicts of Interest – There are no conflicts of interest 35 
 36 
Acknowledgements 37 
Thanks to acknowledge Zhong, Haoyu, MS for figure 1 38 
 39 
Abstract 40 
The term Big Data has come to encompass a number of concepts and uses within medicine.  41 
This paper lays out the relevance and application of large collections of data in the radiation 42 
oncology community.  We describe the potential importance and uses in clinical practice.  The 43 
important concepts are then described and how they have been or could be implemented are 44 
discussed.  Impediments to progress in the collection and use of sufficient quantities of data are 45 
also described.  Finally, recommendations for how the community can move forward to achieve 46 
the potential of Big Data in radiation oncology are provided.   47 
 48 
Introduction 49 
To the clinician, it often seems that we have too much and too little data at the same time.  We 50 
spend more time than we would like at computer terminals entering or reading data.  Perhaps 51 
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information that we can use.  This is the aspect of Big Data that this manuscript addresses. 53 
Computerized data handling has been an integral part of our field since the introduction of 54 
computerized treatment planning and record and verify systems.   The question is, now that 55 
there are highly successful algorithms for using computerized data to make models for 56 
predictive purposes, can the radiation oncology community harness our data for our patients' 57 
benefit? 58 
Pan et al. have provided a very clear picture of the difficulties that we face in collecting and 59 
using data in the clinic [1].  The questions we must answer are: (a) is it worth making an effort 60 
to improve the situation, (b) what are the details of the clinical data environment that need to 61 
be addressed, and (c) how do we accomplish our goals?  An AAPM Science Council Focused 62 
Research Meeting (FOREM) meeting, jointly sponsored with vendors, was held in Ann Arbor in 63 
May of 2017, to address these questions. In this publication we provide an overview and 64 
summary of the answers that emerged.  65 
 66 
Motivation for embracing Big Data 67 
a. Need to learn from and adapt to emerging therapies such as genetics, immunotherapy 68 
It is now commonly understood that the explosion of data and knowledge that has resulted 69 
from genomics will have a great impact on all areas of cancer care, including radiation therapy.  70 
A patient's genetic profile may play an important role in how they will react to certain agents or 71 
in their ability to repair radiation damage [2].  The tumor's genetic profiles (since many tumors 72 
have a multitude of different mutations) is increasingly being used to determine the best 73 
therapy or combination of therapies [3].   74 
Immunotherapy is another area of increasing importance.  The ability to use different aspects 75 
of the immune system to target tumor cells is an area of great current interest [4]. 76 
Radiation oncology is not alone in the interest and need for better data on patieﾐts’ geﾐetiI 77 
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order to avoid the current problems such as laboratory-dependent formats, text-based storage, 79 
and lack of centralized storage in current electronic health records (EHR) [5].  80 
 81 
b. Cancer as chronic disease and multiple care givers 82 
As cancer therapy becomes more effective, more and more patients are living longer. As a 83 
result, the extent and complexity of information which needs to be tracked to improve 84 
understanding of outcomes is increasing.  For example, for patients who are essentially cancer 85 
free, monitoring risk for treatment-related complications when their long term home location 86 
based follow up is not at the treatment center is a challenge.  Parry et al. estimate that there 87 
will be 18 million cancer survivors by 2020 [6].  In addition, there are the increasing numbers of 88 
patients who survive longer than ever due to improvements in targeted therapies, better 89 
imaging and better methods for localizing dose [7].  These advances can lead to improved local 90 
control and better control of oligometastases.  The upshot is that as the number of patients 91 
who suffer cancer-related health consequences increases over time, the more likely it is that 92 
they will see a wider spectrum of specialists and in a larger number of clinical settings, 93 
interacting with a large variety of recording-keeping systems.   94 
Even just considering the electronic health records, there are no general standards for the 95 
selection and formatting of data to be recorded. Different vendors, different institutions, 96 
different departments and even different physicians have different methods which are often 97 
not compatible.  Finally, even within well-structured organizations, much of the data exist 98 
within text documents. Lack of standards for which data elements to gather, inconsistent 99 
processes for entry and variability among commercial systems for aggregation and reporting 100 
increase the likelihood that physicians and staff will miss information or have incorrect 101 
iﾐfoヴﾏatioﾐ ヴegaヴdiﾐg a patieﾐt’s health aﾐd/oヴ tヴeatﾏeﾐts that Iould poteﾐtiall┞ affeIt 102 
decisions.   103 
 104 
















This article is protected by copyright. All rights reserved 
In the last decade, comparative effectiveness research (CER) has come to be seen as an 106 
important and necessary adjunct to randomized clinical trials (RCT) [8].  In CER, two different 107 
theヴapies oヴ tests that aヴe alヴead┞ aIIepted aヴe Ioﾏpaヴed, ┘heヴeas RCT’s foIus oﾐ Ioﾏpaヴiﾐg a 108 
new to a current therapy.  The Patient Centered Outcomes Research Institute cites CER as its 109 
primary method of research.  Given the relatively small numbers of cancer patients that are 110 
eﾐヴolled iﾐ RCT’s ふappヴo┝iﾏatel┞ ン%ぶ, the ﾐeed to use the iﾐfoヴﾏatioﾐ that is a┗ailaHle thヴough 111 
CER is understandable.  112 
Comparative effectiveness research can be tailored along a spectrum of methods ranging from 113 
essentially an RCT to a comparison of current clinical practice with an integrated practice 114 
beyond the current norm.  A recent paper by Fiore et al. looked at four different trials that 115 
sought to use only data in the current EHR’s [9].  Theiヴ IoﾐIlusioﾐs iﾐIluded: さWe find that EHR-116 
based clinical trials are feasible but pose limitations on the questions that can be addressed, the 117 
processes that can be implemented, and the outIoﾏes that Iaﾐ He assessed.ざ   118 
Clearly, for progress to be made using CER practical methods for the easy and accurate 119 
collection of data and for the sharing of data must be available in clinics.   120 
d. Quality Improvement and Error Detection 121 
The past few years have seen an explosion in the use of data to reduce errors in radiation 122 
therapy.  ASTRO and AAPM have implemented the Radiation Oncology—Incident Learning 123 
System (RO-ILS) that relies on data submitted to it to develop a shared learning platform.   124 
While this system is not "big data" in the sense that it is in text format and is a relatively small 125 
amount of data, it does count in our definition of transforming data to information.  In 126 
particular, the system is set up to provide users with more knowledge about the sources of 127 
errors and how best to avoid them.  Another area is in artificial intelligence applications of error 128 
detection. For example, Kalet et al. successfully mined an OIS to develop a probabilistic model 129 
of the contributing factors to errors [10].  130 
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Perhaps the most widespread use of data in radiation oncology is in modeling.  The examples 132 
are too numerous to list, but some of the most impactful models are the QUANTEC models, 133 
outcomes, tumor control probabilities, equivalent uniform dose, and biologically effective dose 134 
[11].  As construction of Big Data Analytics Resource Systems (BDARS) aggregating a wider 135 
range of health care information (e.g. labs, medications, genomics, demographics, patient 136 
reported outcomes (PROs) etc.) expands, more comprehensive models are progressing beyond 137 
dose metrics alone [12-14].  In addition, heuristic type models have been constructed for 138 
automating the objectives of inverse planning and library-based contouring.  A promising area 139 
for the more conventional use of big data is in machine learning for automated contouring.  In 140 
this application, images that have been segmented by experts are fed into a machine learning 141 
algorithm and image features that predict the true contours are selected to produce anatomical 142 
contour models.   143 
 144 
 145 
State of the Data 146 
One of the most important concepts is that Big Data, in most cases, implies more data than may 147 
be obtained by any single institution.  In order to use machine learning or any modeling 148 
techniques, there must be enough data to (a) build the model, (b) test the model, and (c) 149 
validate the model.  Optimally, validation (c) can be done with data from a different institution 150 
in order to account for hidden variables that may not be appreciated [15].  In addition, as our 151 
ability to differentiate patients improves, e.g. genomics and radiomics, the number of patients 152 
suitable for any given model decreases, thereby increasing our need for more comprehensive 153 
capture of intra-institutional data as well as for multi-institutional data.  This has critical 154 
implications for how organizations cooperate.  Whereas success in medical research in the past 155 
has favored very large single institutions that can develop a critical mass of knowledge and 156 
resources in close physical proximity, diffuse networks of institutions able to generate and 157 
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In addition to the need for broad (many patients) data sources, we also need deep 160 
(relationships among key data elements) sources. Systems promoted as big data sources may in 161 
fact be shallow, capturing only a few data elements for a large number of patients. For 162 
example, some data sources draw upon billing records or imaging records for a large number of 163 
patients, but lack depth needed to enable linkage to diagnosis, treatment, dosimetric or 164 
outcomes details. Another impediment to obtaining the "deep" type of data is that sources 165 
ofteﾐ duﾏp uﾐstヴuItuヴed, さas isざ, data iﾐto data lakes ┘heヴe ke┞ data eleﾏeﾐts aﾐd 166 
relationships can in principle be extracted, but in practice carry a high overhead for extraction. 167 
Challenges for ensuring depth in aggregation of key data elements needed for radiation 168 
oncology fall into four categories 169 
◦ Access – Staff possessing both domain knowledge of radiation oncology and of 170 
informatics need access to query data bases in source systems to construct 171 
functional big data repositories.  172 
◦ Data Integrity – Data elements that may not require accurate entry to enable 173 
treatment but are vital for correctly identifying specific patient groups in practice 174 
quality improvement (PQI) and research efforts require changes in clinical processes 175 
to assure validity. This often implies a cultural shift to prioritize recording data in 176 
recoverable formats. 177 
◦ Data Structure – The cost of free text is high. Lack of standardized structure for entry 178 
undermines ability to automate extraction of key data elements from text fields such 179 
as notes. To assure accurate, high volume, electronic extraction of key data 180 
elements standardized methods for encoding key data elements need to be defined 181 
and implemented in clinical processes.  182 
◦ Lack of integration among systems – Key data elements are entered and stored in a 183 
range of commercial systems that frequently do not maintain linkages needed to 184 
identify relationships between key data elements. There is no existing standard of 185 
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large commercial and governmental datasets such as the National Cancer Database 187 
Base.    188 
 189 
 190 
Process and system changes 191 
In reviewing current practices, a number of obstacles stand in the way of obtaining the amount 192 
and quality of data needed to make substantial progress.  The following outline provides a view 193 
that is geared towards identifying means of overcoming them. 194 
(1) Failure to collect necessary structured data 195 
(2) Lack of data standardization  196 
(3) Inability of different electronic data systems to communicate. 197 
Within each of these broad categories, it is useful to provide a finer-grained view of how 198 
different aspects of our clinical and electronic environments contribute to the overall difficulty 199 
in achieving the data collection and use that we seek. 200 
(1.a) Commercial System Databases 201 
Focus for development of commercial systems that store the range of data needed for clinical 202 
data repositories is often on the user interfaces rather than on the back-end databases. The 203 
situation is similar to a clinical focus on data required to tヴeat the da┞’s patieﾐts and support 204 
billing documentation with few resources devoted to standardizations and optimizations to 205 
increase big data extractions. Individual systems may use multiple loosely connected databases, 206 
complex compound keys, lack of indexing, poorly designed schema, lack reasonable security, or 207 
use non-standard database technologies. Vendors may also refuse to provide end-users access 208 
to extract their own data. Some commercial systems are much better than others, so end user 209 
experience is variable.  210 
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Correct usage and quantified entry of diagnosis and staging information is central to many PQI 212 
and research efforts. For example, incorrect entry of primary disease codes (e.g. prostate 185, 213 
C61) when treating subsequent bone (C79.51), brain (C79.31) or lung (C78.00) metastasis and 214 
failure to utilize functionality in radiation oncology information systems (ROIS) to connect 215 
primary and metastatic diagnosis undermine the ability to use these codes to correctly identify 216 
patient groups by codes. Failure to utilize functionality in ROIS connecting treatment courses to 217 
these codes undermines ability to connect treatment elements (e.g. DVH metrics) to patients. 218 
The cost of not taking a few seconds to select ICD-O (International Classification of Diseases for 219 
Oncology) values linked to ICD9 (International Classification of Disease, revision 9) and ICD10 220 
(International Classification of Disease revision 10) in the ROIS means that subsequent 221 
questions about disease site location become prohibitively expensive to answer because of the 222 
manual effort required to retrospectively revisit the chart. When survival information is 223 
obtained from EHRs, failure to utilize functionality in ROIS to enter staging information 224 
undermines ability to factor staging into survival, recurrence and other factors. Typically, EHRs 225 
do not have functionality for quantifying diagnosis and staging information according to 226 
guidelines (e.g. AJCC, FIGO) or to connect primary and metastatic disease. On the other hand, 227 
ROIS generally do, but frequently this functionality is not utilized fully as part of clinical practice.  228 
(1.c) Outcomes 229 
Patient outcomes such as toxicity and disease site status (e.g. recurrence) are frequently 230 
entered into electronic records as free text using unstandardized terminology. This renders 231 
them unavailable for automated electronic extraction. Lack of standardizations 1) for which 232 
toxicities are routinely measured, 2) how treatment site categorizations  are named (e.g. breast 233 
tangents , breast tangents plus supra-clavicular field, breast tangents plus supra-clavicular field 234 
plus internal mammary node field, etc) , 3) how categorizations for disease site status are 235 
named (e.g. no-evidence-of-disease, local recurrence) or 4) in use of  regular schemas for text 236 
representation  of these key data elements prevent this information from being used to its full 237 
value in routine characterization of outcomes for treated patients.  238 
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To assess correlation of outcomes with dose volume histogram (DVH) metrics, it is necessary to 240 
first create treatment plan sums corresponding to the plans and number of fractions treated, 241 
reflecting boosts, plan revisions and incomplete treatments. When these さas treatedざ plan 242 
sums (ATPSs) are created as part of routine practice, then automated solutions for calculating 243 
dose-volume histograms metrics becomes possible. Unfortunately, often these are not created 244 
as part of routine practice, with the result that they must be constructed retrospectively, ad-245 
hoc, preventing systematic, automated aggregation. Currently no major commercial system, to 246 
our knowledge, has a standard means for reporting ATPSs. 247 
(2.a) Prescriptions 248 
Electronic prescription summaries that defined dose levels, target structures, number of 249 
treatments, fractionation groups (e.g first course, plan revision, boosts, etc) and connection to 250 
target structures, organs at risk, treated plans and DVH metrics have been developed by a few 251 
researchers [16,17].  These custom solutions were developed to fill the void left by commercial 252 
ROISs. Recently ASTRO has suggested a baseline set of guidelines for information that should be 253 
included in prescriptions to promote standardization [18]. Similar to ATPSs, commercial 254 
solutions and clinical processes often lack ability to retrospectively extract this key information.  255 
(2.b) Key Treatment Parameters 256 
Ensuring ability to identify which patients were treated with special technologies and details of 257 
those treatments is important to being able to prove their efficacy. Examples include breath 258 
hold technologies, radio frequency or radio-opaque fiducials used for positioning, 259 
immobilization devices, etc. However, commercial systems and clinical approaches to utilizing 260 
those systems are frequently inadequate for retrospectively gathering this data.  261 
(3.a) Integration of Treatment Planning System (TPS) with ROIS 262 
If systems do not use a common database for TPS and ROIS it is difficult to unambiguously 263 
move from the ROIS record of plans actually treated back to specific plans, plan sums and DVH 264 
curves in the TPS. Some vendors may even discard DICOM Unique Identifiers for plans from the 265 
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(3.b) Integration with EHR 267 
ROI“ aﾐd TP“ s┞steﾏs t┞piIall┞ do ﾐot iﾐtegヴate ┘ith EHR’s. CoﾐﾐeItions may be made through 268 
medical record numbers and inferences around dates recorded in respective systems. This is an 269 
area where Health Level 7 (HL7) Fast Healthcare Interoperability Resources (FHIR) could 270 
significantly improve integration.  271 
(3.c) Integration with specialty systems 272 
Treatment devices other than conventional linear accelerators (e.g. brachytherapy, particles, 273 
specialty accelerators, MR guided linacs) may provide minimal details back to the ROIS or may 274 
use specialty tables in the ROIS that do not integrate well with tables used to manage external 275 
beam therapies.  This limits the range of questions around treatment details for these specialty 276 
modalities that can be addressed at large scale for all patients treated.  277 
(3.d) Integration with institutional registry data 278 
Institutions with the American College of Surgeons Commission on Cancer and National 279 
Comprehensive Cancer Network (NCCN) designations are required to have medical registries 280 
that follow up on cancer patients.  Registries document demographics, diagnosis, staging, 281 
survival, cause of death and other factors.  Registry data is rarely linked to radiation oncology 282 
data repositories.  283 
(3.e) Integration with public databases 284 
Institutional registries supply data to state registries.  Published state analyses are, 285 
unfortunately, many years behind current practice. Although state registries have high volumes 286 
of patients, there is no simple means to connect back to patients to check on the validity of the 287 
data or to investigate impact of cofactors on outcomes tracked in the registries.  288 
 289 
Access and Extraction Issues 290 
As radiation oncology has developed, a number of structural issues have arisen that limit 291 
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several key elements: knowledge of the format and schema of the stored data, software that 293 
can identify and extract the data, and permissions to view and extract the data.   294 
Figure 1 illustrates the level of detail that is needed regarding the treatment of rectal carcinoma 295 
patients under three RTOG studies.  To combine the data from these trials requires knowledge 296 
of how the problem is framed (which clinical data are needed, what are the key elements of 297 
those data), how the data are formatted (type of value, allowed values, units, standards if 298 
applicable), and the specific software needed to access the data (SQL, RDF triples, 299 
spreadsheets).   300 
The issue of framing the medical problem is difficult but rewards are high.  The DICOM standard 301 
(and its radiation therapy extension) has achieved such success in large part due to its 302 
structuring of what an imaging study (radiation treatment) is--what are its elements and how 303 
are they related [19].  Thus, regardless of the details of the implementation of a procedure, all 304 
partners in a communication exchange agree on the essential elements.  The definition of such 305 
standards in other areas of medicine is rapidly increasing.  For example, a relatively commonly 306 
used standard for data exchanges between EHR's is the standard Health Level 7 (HL7).  HL7 307 
version 2 standardized types of data and the allowed values and permitted organizations and 308 
vendors to develop software for the reliable interchange of certain data.  However, it was 309 
considered to be quite limited, and version 3 was built around the Reference Information 310 
Model which was a much more robust view of healthcare in general [20].  Even more recently, 311 
they have started developing HL7-FHIR which instantiates an even more up-to-date view of 312 
medical practice, but also highlights the importance of appropriate technology.  HL7-FHIR is 313 
built upon the REST specification that is the current industry standard for web-based 314 
applications [21]. Other data standards, such as the NCI thesaurus [22], provide additional 315 
resources that facilitate the development of software for access and extraction of data.  316 
With rare exception, major vendors of ROIS, TPS and EHR systems, store information in 317 
relational databases. A few types of large volume objects (e.g. DICOM images) are stored in files 318 
that are referenced in the relational databases. Custom extractions from databases are carried 319 
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relational database systems (e.g. Oracle, Microsoft SQL). Ideally, relational databases are 321 
designed with categories of data grouped into tables and views (stored SQL query results) 322 
reflecting an overall view of the procedure itself. They also use normalization strategies to 323 
prevent redundant information, reduce complexity in SQL queries and increase performance in 324 
retrieving data. Secure data retrieval requires granting read access to specific authenticated 325 
network accounts. Access may be controlled at the level of the database, table or views. Skill 326 
with SQL is essential to any staff constructing or extracting data for a data repository. 327 
Application programming interfaces (APIs) are provided by vendors of many TPSs. These may be 328 
used to gather subsets of information stored in the ROIS database or elements only calculated 329 
at run time in the TPS (e.g. DVH curves for some systems). APIs allow custom software 330 
applications to be constructed by users that interface with the TPS. Access is controlled by end 331 
user system administrators, subject to constraints of the commercial system. Clinical staff 332 
members with coding skills are necessary for effeIti┗e use of API’s.  333 
Legacy issues with vendor changes to both database and API structures are an issue for groups 334 
automating extraction from electronic records systems. Effort to re-write queries and scripts 335 
when systems are upgraded can be substantial.  336 
Patient reported outcomes (PROs) are important outcome measures and their routine 337 
monitoring during cancer therapy has been demonstrated to improve survival [23]. However, 338 
use of paper based rather than electronic systems are more common. Electronic systems are 339 
significantly better for making the data accessible, but require substantial effort in setting up 340 
systems and arranging for staffing resources to assist patients with completing electronic 341 
surveys is required. In addition, lack of standardization in instruments to be used, redundant 342 
questions between surveys, excessive length diminishing patient willingness to participate, and 343 
question formats and logic that translate poorly to electronic systems already used in patient 344 
work flows are issues for generalized use of PROs.  345 
Diagnostic images are stored on Picture Archive and Communication Systems (PACS) in Digital 346 
Imaging and Communication in Medicine (DICOM) format and accessed with DICOM servers. 347 
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of patient images. The objective in utilizing these resources in connection with BDARS is not 349 
creation of a parallel PACS. Instead, when large sets of images are identified for utilization in a 350 
study, e.g. developing predictive radiomics measures for a disease type, downloading a large 351 
specific set of images for batch processing is needed. Negotiating access is the primary barrier.  352 
Finally, it is important to discuss the role that legal and commercial considerations play in 353 
limiting access to data.  The Health Insurance Portability and Accountability Act of 1996 354 
requires certain standards to be met when exchanging private health information.  The 355 
standards depend on the intended use of the data, for example, clinical decisions, insurance 356 
coverage, quality improvement and research.  They also depend on the entities exchanging the 357 
information.  These standards add time, effort and new procedures to any effort to obtain data 358 
access.  Intra-institutional exchange, for example between a departmental data repository and 359 
the hospital EHR, is in general easier than between institutions, but even that type of 360 
transaction usually requires some level of administrative oversight and/or procedure.  In 361 
addition, storing data in a clinical data repository for possible future research can be viewed as 362 
problematic under national ethics guidelines for human research [24].  Overall, it is difficult to 363 
make any broad statements or recommendations regarding these issues since they are, to 364 
some degree, institution- and use-specific.  In addition, how the regulations are interpreted is 365 
evolving, particularly in response to some of the national healthcare programmatic initiatives 366 
such as the Affordable Care Act. 367 
Selecting technologies 368 
The objective is to use the treatment data, rather than to utilize a novel database technology. 369 
Selecting database technologies which minimize investment overhead and risk while 370 
maximizing productivity and interoperability for addressing particular tasks requires careful 371 
consideration [25,26]. 372 
At a high level, four process steps can be considered and technology choices should be made 373 
fit-for-purpose for these steps.  374 
















This article is protected by copyright. All rights reserved 
The primary use for health care data is delivery of patient care. Health care database 376 
technology is often vendor dependent and under regulatory oversight. For structured data 377 
elements (e.g. record and verify, electronic health records, outcome) relational databases are 378 
the most common technologies. Images and related objects such as treatment plans and record 379 
are generally object stores (e.g. PACS) with a relational schema containing object pointers.  380 
2. Extraction 381 
Since the primary use sources have to be taken as-is, the extraction technologies providing 382 
connectors to these primary sources should be able to handle many different sources and 383 
formats including all common relational sources. They should be able to handle non-relational 384 
souヴIes iﾐIludiﾐg さdataHasesざ that ヴeseaヴIheヴs aﾐd ph┞siIiaﾐs ofteﾐ use ふe.g. E┝Iel, “P““ぶ aﾐd 385 
include JSON and XML support as these are common export format for more technical users. 386 
Ideally, the technology can be extendible to support common medical standards (HL7v2, HL7v3, 387 
HL7 FHIR and DICOM) as needed.  388 
A wide range of programming languages and standard database import tools are frequently 389 
used. These have the advantage of hiding very little from the user. There are also commercial 390 
and open source software systems intended to reduce the technical skill requirements for users 391 
with the trade-off of obscuring details about the extraction, cleaning and loading processes. 392 
Since primary sources change and extraction tools generally expand and change over time, a 393 
crucial requirement is versioning. Users of technology should be able to store different versions 394 
of the extraction scripts and configurations so that subsequent users can re-use their solutions. 395 
3. Transformation, integration and storage 396 
For successful secondary use, the primary use sources need to be combined, integrated and 397 
common data elements mapped on each other. An example is the combination of ROIS/EHR 398 
data (diagnosis, comorbidities, prescriptions, treatments, follow-up), Record and Verify data 399 
(radiotherapy treatment) and DICOM data (imaging/plan). This transformation and integration 400 
is generally the most time consuming task of the process. Knowledge of the primary sources 401 
and of the secondary use data model is a requirement for staff using the tool. Again, versioning 402 
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needed for work to not be duplicated. Defining distinctions between data element categories 404 
and relationships means mapping the raw values onto a schema. For example, a schema needs 405 
to be applied so that we can inform our analytics programs if an e┝tヴaIted ┗alue さンヰざ 406 
corresponds to a dose, an age, a day of the month, etc. and how that value relates to other 407 
information e.g. toxicity, survival, PROs, treatment dates, etc. 408 
From a technology standpoint two main approaches exist. 409 
 Schema-On-Aggregate (aka schema-on-write): Upon extraction each data 410 
element from each source is considered more or less separately, transformed 411 
and mapped to the secondary use data model and then written in the secondary 412 
use data store. Schema-on-aggregate has as its main benefit that it often re-uses 413 
the knowledge contained in the primary use schema and forces one to decide up 414 
front how to map data items and think about transformation for each data 415 
element. The end-result is often a data store with a structured schema. 416 
Relational databases are widely used for this approach owing to their speed, 417 
ease of integration with other systems and large pool of talent for use. Non-418 
relational databases (e.g. object stores, graph databases and triple stores) have 419 
also been used in some research settings. 420 
 Schema-On-Query (aka schema-on-read):  The secondary use data model is 421 
applied when the secondary user requests, or queries, the data from the 422 
secondary source. In a schema-on-query system the data is stored from the 423 
pヴiﾏaヴ┞ souヴIe さas-isざ aﾐd H┞ ﾐeIessit┞ this is a ﾐoﾐ-relational store (e.g. a data 424 
lake). An example is Apache Hive which can be used for SQL-like schema-on-425 
query for Apache Hadoop. NoSQL databases, such as MongoDB or CouchDB, are 426 
another example. The main benefit of this approach is that the transformation 427 
and secondary use data model can be defined fit-for-purpose, and different for 428 
different use cases. Also all primary use data can be stored immediately for later 429 
secondary use. The main drawback is that knowledge of original schema is often 430 
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identification. Variability in nomenclature for key data elements, relationships 432 
aﾐd foヴﾏats aﾏoﾐg the ┗aヴious さas-isざ souヴIes ヴeケuiヴes Iヴeatiﾐg aﾐd ﾏaiﾐtaiﾐiﾐg 433 
custom code for each to enable programmatic extraction. Care must be taken to 434 
ensure consistent meaning at the time of data entry so that contents of an 435 
element are internally consistent and stable.  436 
 437 
Note that many solutions allow a combination of the above approaches, with some data 438 
elements stored in a schema generation upoﾐ aggヴegate aﾐd soﾏe stoヴed さas-isざ foヴ sIheﾏa at 439 
a later time point. In that case, key data elements are often duplicated into the secondary use 440 
storage.  441 
 442 
Secondary use application  443 
Secondary use of subsets of data extracted from BDARS to address specific research or clinical 444 
questions is a common use case. The secondary user usually has defined their own data model, 445 
store and the application to analyze the data. The technology choices made by secondary users 446 
vary widely and limited influence exists especially if the secondary user is external to the 447 
primary use institution. The main job of technology here is to provide the secondary end-user 448 
with a dataset and format which he or she can use (often called a data mart). Typical requested 449 
formats include SQL database dumps, Microsoft Excel, comma (or tab) separated values (CSV), 450 
DICOM, HL7 FHIR, HL7v3, HL7v2, XML and JSON. Additionally, data visualization and allowing 451 
the end-user to navigate the data store established in the previous step increase the efficiency 452 
and effectiveness of secondary use. The tools mentioned above generally allow such export to a 453 
variety of data formats. Figure 1 illustrates one such use case, a semantic triple store database 454 
(a.k.a. Resource Description Framework) was applied for the purpose of combining datasets 455 
from several clinical trials. Semantic triples can be used to define a range of relationships 456 
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Specific recommendations for work flows and standardizations  459 
1) Diagnosis and staging data should be entered into quantified fields in accessible, electronic 460 
systems that  461 
◦ have quantified fields for staging elements and overall staging, and staging guideline 462 
system used (e.g. American Joint Committee on Cancer (AJCC)) 463 
◦ ensure correct selection of staging from component elements 464 
◦ provide explicit linkage to treatment courses and plans used to treat  465 
◦ link metastatic diagnosis (e.g. C79.51, Secondary malignant neoplasm of bone) to 466 
diagnosis for originating sites (e.g. C34.1, Malignant neoplasm of upper lobe, 467 
bronchus or lung) 468 
 469 
        In the current vendor landscape, the ROIS is frequently the only system in the clinical 470 
process workflow meeting these objectives.   471 
 472 
2)   Nomenclature standardizations recommended by AAPM Task Group 263 should be adopted 473 
into routine practice. These define standardized nomenclature for structure, target and 474 
DVH metric naming to promote ability to automate aggregation [27].  475 
 476 
3)  Course cumulative as-treated plan sums should be constructed as part of routine practice. 477 
Since more than one image set may be used in the construction of the ATPS’s, and relative 478 
positioning of structures may vary between sets, using the image set providing the best 479 
representation for the clinical evaluation carried out for treatment is currently the most 480 
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4)    Toxicities, recurrence and PRO outcomes need to be routinely collected as quantified fields 483 
(instead of free text fields) in accessible electronic systems. Standardizations for specific 484 
items and values are needed. This includes, for example, definition of recurrence 485 
nomenclature. Ability to automatically recover these values from the electronic record is 486 
important.  487 
 488 
5) Detailing of key data elements and relationships (i.e. an ontology) is needed for a broad 489 
range of practice quality improvement and translational research efforts. An initial set, drawn 490 
from experience in constructing BDARS, is presented as an appendix to this paper. Success in 491 
gathering this information requires that clinical systems should be utilized to ensure ability to 492 
accurately aggregate these elements and relationships from the electronic record (ROIS, TPS, 493 
EHR).  Ideally, professional societies such as ASTRO, AAPM, ESTRO and CARO would combine 494 
efforts to eventually take the role of maintaining standardized ontologies to promote 495 
interoperability among institutions and commercial systems. Combining the ontology presented 496 
in the appendix with related ontologies would be a valuable step toward a common standard 497 
[28,29]. 498 
 499 
6) In addition to demonstrating adherence to standard quality metrics, clinical entities will face 500 
increasing demands for demonstration of the value of the care they deliver as medicine in the 501 
transitions from fee for service to value based payments.  Success in the value based payment 502 
environment will require the ability to conduct on-demand analysis of patient and tumor 503 
characteristics, all aspects of treatment delivery, outcomes, and cost of care.  504 
 505 
We note that the task of creating ATPSs (item 3) needs to begin as soon as possible, guided by 506 
clinical judgment, in order to replace complete lack of data with reasonable data. In addition, 507 
further refinement is needed.  Collaborations between professional societies, vendors and 508 
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needed. Issues include means to quantify quality of the composite, identifying source images, 510 
identifying trade-off decisions in image registrations, uncertainties in structure dosimetric 511 
measures when multiple image sets are used, and realistic appraisal of the role of image 512 
deformation.  513 
Examples of Clinical Data Repositories  514 
Several groups have been actively engaged in construction of clinical data repositories (CDR), 515 
also known as data lakes and Big Data Analytic Resource Systems (BDARSs). These systems 516 
become important components for both research and clinical practice efforts in their clinics. 517 
Practical recommendations from this group have been grounded in the experience of 518 
constructing, using and sharing these systems. Brief summaries of several are highlighted to 519 
convey the scope and volume of these resources.  520 
 The University of Michigan Radiation Oncology Analytics Resource (M-ROAR) automates 521 
aggregation of electronic data from the Treatment Planning System (TPS), Radiation 522 
Oncology Information System (ROIS), Electronic Health Record (EHR) and other 523 
databases for all patients treated. Data types include demographics, treatment and 524 
dosimetric data, chemotherapy, toxicities, comorbidities, labs, medications, encounters 525 
and patient reported outcomes (PROs). The system contains records for over 20,000 526 
patients. Key data elements are extracted utilizing a combination of SQL queries, TPS 527 
application programming interface (API) based scripts and custom code to extract and 528 
process data from multiple source systems [25]. 529 
 The UCLA Clinical Informatics Management System (CIMS) consists of three major 530 
modules: a physician interaction module that interacts closely with EHR, a physics 531 
parameter module that handshakes with PACS systems, treatment planning and delivery 532 
stations for quantitative value collection and exchange, and a patient reported outcome 533 
management system (Patient Reported Outcomes Measurement Information System, 534 
PROMIS) with a web/mobile portal. The physician interaction module supports 535 
comprehensive query for collection and integration of radiotherapy relevant 536 
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module consists of a front-end with site-specific patient-oriented Common Terminology 538 
Criteria for Adverse Events (CTCAE) questionnaires tailored to patients.  As of now, the 539 
registry contains records for 1790 definitive prostate treatment, 209 post-operative 540 
prostate treatment, 1950 breast, 663 lung, 531 brain metastasis, 484 GYN, 424 glioma, 541 
409 meningioma, 209 rectum, 151 metastatic bone, 164 trigeminal, 111 pancreas, and 542 
over 3000 general cases [30]. 543 
 The Ohio “tate Uﾐi┗eヴsit┞ Radiatioﾐ OﾐIolog┞ Depaヴtﾏeﾐt’s さQualit┞ DataHaseざ has 544 
been designed to serve as a data aggregation platform to capture clinical, technical, and 545 
health outcome data on all patients who receive radiation treatments. All data are 546 
stored in a REDCap database.  Smart texts have been implemented in EHR to enable 547 
automated capture and extraction of discrete data elements such as adverse events 548 
from provider notes. The dosimetry data foヴ ヴadiatioﾐ theヴap┞ aヴe e┝tヴaIted ┗ia TP“’s 549 
API. Demographics, diagnosis, tumor biomarkers, surgery, systemic therapy, radiation 550 
therapy, and adverse events constitute the collected data and provide means for 551 
determining effectiveness of treatment modality. The Quality Database currently 552 
contains 3385 patients and is being populated prospectively with new patient data. 553 
 Oncospace: Johns Hopkins University developed a comprehensive data collection and 554 
data repository system [31].  The system consists of a network of data collection 555 
systems (ROIS, clinic computer terminals, mobile devices, hospital EHR) that provides 556 
data that is transformed and loaded into a SQL database.  Using a federated database 557 
approach (including University of Washington, University of Virginia, Odette Cancer 558 
Center-Sunnybrook), each institution has implemented compatible schemas so 559 
federation-wide queries will succeed.  This approach has the advantages of 560 
"crowdsourcing" ideas and technology and allowing each institution to keep control of 561 
their data while still permitting individual flexibility.   562 
 The Veterans Health Administration (VHA) developed a pilot Radiation Oncology 563 
Practice Assessment (ROPA) program to assess the quality of radiotherapy across the 564 
















This article is protected by copyright. All rights reserved 
metrics targeted at workup, diagnosis, treatment planning, delivery and follow-up. The 566 
gathered quality metrics were developed by the VHA in partnership with ASTRO for 567 
locally advanced non-small cell lung cancer, limited stage small cell lung cancer, and 568 
intermediate and high-risk prostate cancer. Data extraction for the initial pilot project 569 
will be completed in 2018. At that time ROPA is anticipated to contain 45,000 scores for 570 
49 metrics aggregated from approximately 2,000 patients.  571 
 572 
Large data sets from sources outside of radiation oncology are now available for 573 
analysis.  Waddle et al. recently published utilization data derived from insurance 574 
records from a commercial warehouse (Optum Labs) to examine treatment technologies 575 
used (proton, stereotactic body radiotherapy, IMRT, 3D, other) by diagnosis code used 576 
in billing records. The data base contains utilization data on a subset of 474,533 577 
radiation oncology patients from a larger database of over 100 million insured lives. 578 
However, connection of this data to clinical outcomes and other cofactors was pending 579 






Recommendations for next steps needed to improve data availability. 586 
Adopting national standards 587 
As discussed above, an important aspect of data exchange is employing a generally recognized 588 
view of the medical process.  HL7 FHIR is an emerging standard and one that has the crucial 589 
elements of (a) flexibility, (b) state-of-the-art technologically, and (c) widespread support [34]. 590 
As this standard is just not being formalized, this is an excellent time for the radiation oncology 591 
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Increasing multi-institutional collaborative efforts 594 
Real, effective standards emerge from being actively engaged in exchanging data with outside 595 
groups as part of more frequent collaborations. Professional and government grant support for 596 
research efforts that develop and proof these standards as by-products are important to their 597 
emergence.  598 
Included in this effort is need to facilitate information exchanges that support re-treatment. As 599 
patients are able to survive longer with cancer, likelihood of visiting more than one center for 600 
subsequent treatments increases.  Clinical process and data exchange standardizations needed 601 
to facilitate these exchanges also support collaborative efforts.  602 
 603 
Links to institutional registries 604 
Institutions which are members of the National Comprehensive Cancer Network (NCCN) are 605 
required to have access to a registry which carries out longitudinal follow-up on a few key data 606 
elements (e.g. survival, cause of death) for treated patients. EHR database records may be 607 
substantially different from registry database records. Providing electronic access registry 608 
databases provides opportunities to synchronize data sources in constructing big data analytics 609 
resource systems.  610 
 611 
Support for Public Data Sets 612 
The value of producing data sets that can be publicly shared (without compromising PHI) has 613 
been heralded by several authors. [36-38]. There is growing interest from funding agencies for 614 
publicly funded research to produce publically available datasets. Similarly, an increasing 615 
number of journals require publication of datasets accompanying findings. Recently Medical 616 
Physics has introduced a special publication category just for data sets. Principles for ensuring 617 
that data are findable, accessible, interoperable, and reusable (FAIR) for public access of data 618 
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The National Cancer Institute has recently begun to implement a Cancer Research Data 620 
Commons which meet the standards of FAIR.  In their announcement, they echo a number of 621 
the themes that we have set forth in this article.  This is clearly a propitious time for radiation 622 
oncology to join with others in the oncology fields to make these sorts of community-wide 623 
efforts more productive [41]. 624 
Informatics Training 625 
Clinical staff bring great value to informatics efforts because of the depth of their clinical 626 
domain knowledge with respect to key data elements, their inter-relationships, clinical 627 
processes by which data is entered, end user expectations for meaning, etc. The set of clinical 628 
staff that take on expanding their informatics skills to include database, programming, 629 
statistical analysis and machine learning also improve ability to develop practical solutions 630 
bridging needs between the larger number of specialists entirely focused in either the clinical or 631 
informatics domains.  632 
Conclusions 633 
We have laid out an argument for why it is important for the radiation oncology community to 634 
improve the means by which we can collect, share and use the data that we encounter every 635 
day.  However, for various reasons, much of this data remains inaccessible to us in a format 636 
that makes it easy for us to transform data to knowledge.   637 
The technological challenges to implementing a community-wide system of data collection, 638 
sharing and usage are formidable but the tools have been or are currently being developed.  639 
More difficult is developing the collective will to make it happen.  Such a change in our clinical 640 
behavior and workflow requires buy-in from everyone, including clinic staff, physicians, and 641 
vendors.  It is our hope and expectation that this sea change has already started to occur as 642 
diffuse networks grow in size and analytic power.  It is necessary to do so if we are to continue 643 
to be at the forefront of harnessing technological advances to improve the treatments that we 644 
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CDR: Clinical Data Repository 660 
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CTCAE: Common Terminology Criteria for Adverse Events  662 
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EHR: Electronic Health Record 667 
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FIGO: International Federation of Gynecology and Obstetrics 670 
HIPAA: Health Insurance Portability and Accountability Act 671 
HL7: Health Level 7 672 
ICD-O: International Classification of Diseases for Oncology 673 
ICD9: International Classification of Diseases, Ninth Revision 674 
ICD10: International Classification of Diseases, Tenth Revision 675 
JSON: JavaScript Object Notation 676 
NCCN:  National Comprehensive Cancer Network 677 
NIH: National Institutes of Health 678 
OIS: Oncology Information System  679 
PACS:  Picture Archive and Communication Systems 680 
PHI: Protected Health Information 681 
PQI: Patient Quality and Improvement 682 
PRO: Patient Reported Outcome 683 
PROMIS
 
 :Patient-Reported Outcomes Measurement Information System 684 
REDCap: Research Electronic Data Capture 685 
ROIS: Radiation Oncology Information System 686 
RCT: Randomized Controlled Trial 687 
ROILS: Radiation Oncology Incident Learning System 688 
RTOG: Radiation Therapy Oncology Group 689 
SQL: Structured Query Language 690 
TPS: Treatment Planning System 691 
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We have defined of a common set of key data elements and relationships important to a broad range of 793 
patient quality improvement and translational research efforts. Ranking treatment information for 794 
effectiveness requires a broad scope of information types: Radiation Treatments, Surgery, Outcomes, 795 
etc. While it is desirable to have all the data readily available, that is not a practical starting point. Our 796 
objective here is to define a minimal set of information needed to handle frequently encountered 797 
questions as a common use starting point.  With that, technical and procedural efforts attempting to 798 
automate electronic aggregation supporting Big Data efforts can use these recommendations as a guide.  799 
Optimally professional organizations (e.g. AAPM, ASTRO, ESTRO, CARO) would establish an official listing 800 
of key data elements and relationships. Our intention here is to provide a practical starting point from 801 
our experience in aggregations from multiple source systems.  802 
The listing of key data elements and relationships define an explicit conceptualization of a body of 803 
formally represented knowledge about Radiation Oncology, i.e. an ontology [42] The listing provided 804 
here was based on the ontology developed for M-ROAR [25] and expanded as an outgrowth of 805 
discussions at the Practical Big Data Workshop.  Incorporation of the ontology into a programmatic form 806 
using Ontology Web Language (OWL) is underway.  807 
Classes () of information, list key data elements (aka properties) denoted by one of three symbols ( ,  808 
,  ). Most elements () do not require special consideration for protection of patient health 809 
information (PHI). Elements that contain PHI (), are problematic for data sharing or storage in cloud 810 
based systems. Alternatives (), containing, reduced information, may be sufficient for a wide range of 811 
collaborative efforts or cloud based storage.  812 
For example, dates are a type of patient health information (PHI) that institutional review boards (IRB) 813 
will not allow for many applications. For a wide range of investigations, detailing temporal relationships 814 
Het┘eeﾐ e┗eﾐts is iﾏpoヴtaﾐt. ReIoヴdiﾐg the patieﾐt’s age at the e┗eﾐt, ヴatheヴ thaﾐ the date foヴ the 815 
e┗eﾐt is aﾐ alteヴﾐati┗e. Foヴ e┝aﾏple, if the date of aﾐ e┗eﾐt is ン/ヲ/ヲヰヱン, aﾐd the patieﾐt’s date of Hiヴth is 816 
8/ヱΑ/ヱ9ヶΑ, theﾐ the patieﾐt’s age at the tiﾏe of the e┗eﾐt, to thヴee deIiﾏal plaIes ふDeIiﾏal Fンぶ, is 817 
45.541. This is sufficient resolution to differentiate day on a timeline and meets requirements for 818 
protecting PHI.  819 
Several key data elements typically are not present as distinct values in source data systems but have to 820 
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of an event is derived from date of birth and date of the event. Starred (*) items indicate particular need 822 
for recommendations of standardized values recommendations from professional societies.  823 
When elements have only one instance they are indicated by the name of the class or element (e.g. 824 
DateOfBirth, Patient). When there may be more than one instance of an element, this is indicated by 825 
specifying a list of elements of this class (e.g. List<Course>).   826 
 Relationships among classes are categorized as Parent(), Child(), Sibling () or Property(). Parent-827 
Child are dependent relationships: a parent class object is referenced in each instance of a child class 828 
object. Sibling relationships are tracked if elements exist but do not imply dependence. Sibling 829 
relationships rather than parent-child relationships may be selected when the current state of the data 830 
will not practically support the dependent relationship. For example, Prescriptions are used in sibling 831 
relationships with respect to TreatedPlans because the current state of electronic data is inadequate to 832 
assure consistent mapping. Property relationships are used when class incorporates a set of elements 833 
grouped under a single concept.   834 
 Patient - 835 
 PatientMRN (String) -:Medical Record Number  836 
 PatientGUID (String): Generalized Universal Identifier that can be used in cloud 837 
based storage, when PatientMR is not.  838 
 DateOfBirth (Date) 839 
 YearOfBirth (Int?)  840 
 DateLastSurvivalCheck (Date?) 841 
 AgeAtLastSurvivalCheck (Decimal F3)  842 
 DateOfDeath (Date?) 843 
 AgeAtDateOfDeath (Decimal F3)  844 
 IsAlive (Bool) – Status at last at Last Survival Check Date 845 
 *CauseOfDeath (String)  – Need for standardized list  846 
 Gender (String) 847 
 Race (String) 848 
 Ethnicity (String) 849 
 850 
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 List<Radiation Therapy Course>  852 
 List<Prescription> 853 
 List<DiagnosisAndStaging> 854 
 List<TreatedPlan> 855 
 List<PatientTreatmentOutcome> 856 
 List<PatientReportedOutcome> 857 
 List<PlanningStructureSet> 858 
 List<HealthInformation>  859 
 List<Lab>  860 
 List<Medication>  861 
 List<Image>  862 
 List<Chemotherapy Course>  863 
 List<Surgical Procedure> 864 
 List <Pathology> 865 
 List <Charge> 866 
 867 
 868 
 RadiationTherapyCourse  – These are the treatment courses. A course Every patient has a list of 869 
courses 870 
 CourseName (String) 871 
 NTxSessionsInCourse (Int)  – Each treatment episode is a session, sessions used for 872 
imaging only are exclude from the count  873 
 DateFirstTreatment (Date) 874 
 AgeAtFirstTreatment (Decimal F3)  875 
 DateLastTreatment (Date) 876 
 AgeAtLastTreatment (Decimal F3)  877 
 878 
Sibling Class Relationships 879 
 List<Prescription> 880 
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 List<Surgical Procedure> 882 
  883 
Child class relationships 884 
 List<TreatedPlan> 885 
 List<DiagnosisAndStaging> - Typically only one per Course 886 
 List<PatientTreatmentOutcome> - Typically only one per Course 887 
 List<Charge> 888 
 889 
Parent Class Relationships 890 
 Patient 891 
 892 
 Prescription : The prescription needs to fully convey the intent of the physician for the treatment 893 
plan. The Course contains a list of prescriptions 894 
 Name (String) 895 
 NTxSessions (Int)  896 
 NTxPerDay (Int)  897 
 DaysBetweenTxSessions (Decimal)  898 
 StartOnNthDayFromCourseStart (Int)  899 
 StartOnNthSessionInCourse (Int)  900 
 RxDoseUnits (String) – さIG┞ざ oヴ さG┞ざ oヴ さCGEざ 901 
 IsCourseCummulativePrescription (Bool)  – Only one value of True per Course 902 
 903 
 904 
Class Property Relationships 905 
 List<PrescriptionDoseLevel> 906 
 List<PrescriptionDVHObjectives> 907 
 908 
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 List<TreatedPlan> 910 
 911 
Parent Class Relationships 912 
 DiagnosisAndStaging 913 
 Patient 914 
 Course 915 
 916 
 917 
 PrescriptionDoseLevel 918 
 RxDose (Decimal F3) 919 
 RxStructure (String)  – AAPM TG263 compliant name 920 
 RxPointName (String)  921 
 922 
Parent Class Relationships 923 
 Prescription 924 
 925 
 PrescriptionDVHObjectives 926 
 Structure (String)  – AAPM TG263 compliant name 927 
 DVHMetric (String) – AAPM TG263 compliant name e.g. Max[Gy], V20Gy[%] 928 
 Constraint (String)  - allowed values are =,<,г,>, д, ALARA 929 
 Value (Decimal F3) – null if constraint is ALARA 930 
 931 
Class Property  Relationships 932 
 Prescription 933 
 934 
 DiagnosisAndStaging 935 
 StagingSystem (String) - e.g. AJCC 7, FIGO 936 
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 ICD0 (String) – Defines location of disease 938 
 Laterality (String) – Left, Right, Bilateral 939 
 Overall Staging (String): e.g. IIa, X,  940 
 T (String) 941 
 N (String) 942 
 M (String) 943 
 P (String) 944 
 G (String) 945 
 OtherStagingComponents (String)-Staging components other than T,N,M,P,G 946 
 PrimaryOrMetastatic (String) – Eitheヴ さPヴiﾏaヴ┞ざ oヴ さMetastatiIざ  947 
 948 
Child Class Relationships 949 
 PatientTreatmentOutcome 950 
 DiseaseSiteStatus 951 
 952 
Parent Class relationships 953 
 PrimaryICD9Or10? – If Metastatic, indicate Primary DiagnosisAndStaging element  954 
 Course  955 
 Patient 956 
 957 
 958 
 DiseaseSiteStatus 959 
 DateOfStatus (Date) 960 
 AgeAtDateOfStatus (Decimal F3)  961 
 *Status(String) – Need standardized list e.g. (No Evidence of Disease, Local Recurrence, 962 
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 TreatedPlan : Every course has a list of treated plan objects. One table for all types of plans defining 967 
key elements to track. This simplifies mixed modality tracking e.g. External + Brachy and handling of 968 
individual plans vs plan sums. Only plans actually treated are tracked. Details of actual vs number of 969 
fractions delivered are tracked.  970 
 PlanName (String): Corresponds to PlanID in ARIA 971 
 *TreatmentAreaClassifier (String) : e.g. Head and Neck, Lung_L, Breast_R+SC 972 
 TPSSourceSystem (String)   973 
 IsCourseCummulativePlan (Bool): The plan or plan sum(ATPS) represents all plans treated in 974 
the course 975 
 IsPlanSum (Bool): The dose associated with the plan is created by summing dose from other 976 
plans 977 
 978 
 DateOfFirstPlanTreatment (DateTime) 979 
 AgeAtFirstPlanTreatment  980 
 DateOfLastPlanTreatment (DateTime) 981 
 AgeAtLastPlanTreatment  982 
 983 
 PrimaryTxDeliveryFacility (String) – Facility where most of plan fractions were delivered 984 
 PrimaryTxDeliveryMachine (String) – Machine on which most of the plan fractions were 985 
delivered 986 
 NFractions_Planned (Int) 987 
 NFractions_Delivered (Int) 988 
 TotalDose_Planned (Decimal) – Dose  planed for highest dose structure e.g. PTV_High 989 
 TotalDose_Delivered (Decimal) – Dose  delivered for highest dose structure e.g. PTV_High 990 
 TotalDose_Units  (String) – Gy, cGy, CGE 991 
 992 
 UsedFiducials (Bool)  993 
 FiducialType (String) – Gold, Calypso, Carbon 994 
 UsedBreathMotionControl (Bool)  995 
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 MeanSessionTimeMinutes(Int)  998 
 MeanSessionBeamOnTimeMinutes (Int)  999 
 MeanSessionImagingTimeMinutes (Int)  1000 
 1001 
 NImages_MV (Int)  - Total number of MV images for all sessions treating this plan 1002 
 NImages_kV (Int)  - Total number of kV images  for all sessions treating this plan 1003 
 NImages_CBCT (Int)  :Total number of CBCT for all sessions treating this plan 1004 
 NImages_MR (Int) : Total number of MR images for all sessions treating this plan 1005 
 1006 
 List<SupplementalTreatmentDetail> 1007 
      1008 
Sibling Class Relationships 1009 
 Prescription 1010 
 List<Images> - Image Class Objects related to the TreatedPlan e.g. CBCT, kV 1011 
 1012 
Child Class Relationships 1013 
 PlanningStructureSet 1014 
 List<DVHCurve> 1015 
 List<DVHMetric> 1016 
 List<PatientPositioningDevice> 1017 
 TreatmentPlanDetails_XRT 1018 
 TreatmentPlanDetails_Brachy 1019 
 TreatmentPlanDetails_Particles 1020 
 PlanningStructureSet 1021 
 1022 
Parent Class Relationships 1023 
 Patient 1024 
 Course 1025 
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 1027 
 1028 
 PlanningStructureSet 1029 
 StructureSetName (String) 1030 
 ImageModality (String) : e.g. CT, MR 1031 
 DateOfImageAcquisition (Date) 1032 
 AgeAtImageAcquisition (Decimal F3) 1033 
 DICOMImage_UID (String) DICOM_UID of image use for the plan. In the Image list attached 1034 
to the patient. 1035 
 DICOMPlan_UID (String) 1036 
 DICOMStructure_UID (String) 1037 
 DICOMDose_UID (String) 1038 
 PatientPosition (String) 1039 
 1040 
Parent Class Relationships 1041 
 Patient 1042 
 TreatedPlan 1043 
 1044 
 PatientPositioningDevice 1045 
 *DeviceCategory (String) – Need standardized list 1046 
 DeviceName(String) 1047 
 SetupDetails (String) 1048 
 1049 
 1050 
 TreatmentPlanDetails_XRT 1051 
 List<EnergyModality> 1052 
 TotalPlanMU (Decimal) 1053 
 UsedIMRT (Bool)  1054 
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 UsedFIF (Bool)  1056 
 UsedWedges (Bool)  1057 
 UsedBolus (Bool)  1058 
 UsedNonCoplanarBeams (Bool)  1059 
 NBeams (Int)  1060 
 NFractionsPlanned (Int) 1061 
 NFractionsDelivered (Int)  1062 
 List<SupplementalTreatmentDetail> 1063 
       Parent Class Relationship 1064 
 TreatedPlan 1065 
 1066 
 1067 
 TreatmentPlanDetails_Brachy 1068 
 List<EnergyModality> 1069 
 NSourcesTotal (Int) 1070 
 TotalActivity (Decimal) 1071 
 *TotalActivityUnits (String)- Need standardized list e.g. MBq, Ci, mCi, GBq 1072 
 UsedRadiopharm (Bool) 1073 
 UsedApplicator (Bool) 1074 
 TotalHDRDwellTimeMin (Decimal) 1075 
 TotalPDRDwellTimeMin (Decimal) 1076 
 TotalLDRImplantTimeMin (Decimal) 1077 
 List<SupplementalTreatmentDetail> 1078 
 1079 
Child Class Relationships 1080 
 List<Applicator> 1081 
         1082 
       Parent Class Relationship 1083 
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 1085 
 1086 
 Applicator 1087 
 *ApplicatorType (String) Need standardized list e.g. Needle, BrachyCath, TandemAndOvoid, 1088 
Cylinder, Mamosite, Savi 1089 
 NApplicatorsInserted (Int)  1090 
 NApplicatorsUsedInTx (Int)  1091 
 1092 
Parent Class Relationships 1093 
 TreatmentPlanDetails_Brachy 1094 
 TreatmentPlanDetails_Particles 1095 
 List<EnergyModality> 1096 
 UsedPassiveScattering (Bool) 1097 
 UsedSpotScanning (Bool) 1098 
 UsedEndOfRangeToSpareCriticalOAR (Bool) 1099 
 List<SupplementalTreatmentDetail?> 1100 
        Parent Class Relationships 1101 
 TreatedPlan 1102 
 1103 
 EnergyModality 1104 
 Energy (String) – Need standardized list e.g.  X06, X06FFF, X10, X10FFF, E06, E09, E12, E16, 1105 
E20, Ir192, I125, P70, C250 1106 
 *Modality (String) – Need standardized list e.g. XRT, HDR, LDR, Proton, CyberKnife, 1107 
GammaKnife 1108 
 1109 
        Parent Class Relationship 1110 
 TreatedPlanDetails_XRT 1111 
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 TreatedPlanDetails_Particles 1113 
 1114 
 1115 
 SupplementalTreatmentDetail 1116 
 Name (String) 1117 
 Value (String) 1118 
 ValueType (String) 1119 
 1120 
Parent Class Relationships 1121 
 TreatedPlanDetails_XRT 1122 
 TreatedPlanDetails_Brachy 1123 
 TreatedPlanDetails_Particles 1124 
 TreatedPlan 1125 
 1126 
 1127 
 Image : Information about image objects relevant to patieﾐt’s tヴeatﾏeﾐt 1128 
 ImageName (String) 1129 
 DICOM_UID (String) 1130 
 ImageModality (String)  e.g. CT, kV, CBCT, MR-T1w, MR-T2w,PET,etc 1131 
 SourceSystem (String)  Where to find the image and how to get it e.g. ARIA, Velocity, 1132 
Hospital PACS, etc 1133 
 AccessionNumber (String) 1134 
 StudySeries (String) 1135 
 BodySite (String) 1136 
 DateOfImageAcquisition (Date) 1137 
 AgeAtImageAcquisition (Decimal F3)  1138 
 RelevanceComment (String?) e.g. TumorResponse 1139 
 1140 
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 List<ImageDataFeature> 1142 
 TreatedPlan 1143 
 Course 1144 
 1145 
Parent Class Relationships 1146 
 Patient 1147 
 1148 
 DVHCurve : Store the DVH curve for as treated (i.e. number of fractions delivered) plans and plan 1149 
sums. Every Treated Plan has a list of DVH curves 1150 
 StructureName (String) – Use TG263 Standardization 1151 
 Volume[cc] (Decimal) 1152 
 Min[Gy] (Decimal) 1153 
 Max[Gy] (Decimal) 1154 
 Mean[Gy] (Decimal) 1155 
 Median[Gy] (Decimal) 1156 
 Stdev[Gy] (Decimal) 1157 
 DVHCurve (String)  – Dose, Volume tuples separated by semi colons. Dose is in units of Gy, 1158 
Volume is in units of percent of structure volume e.g. 0,100; 50,100;50.5,99.ヵ;…. 1159 
 1160 
Sibling Class Relationships 1161 
 List<DVHMetric>  1162 
 1163 
        Parent Class Relationships 1164 
 TreatedPlan 1165 
 1166 
 DVHMetric : Metrics provide quick look up of most important values. Sibling relationship to DVH 1167 
curves is maintained so that they can be reported separately if needed.  1168 
 StructureName (String) - Use standard nomenclature from TG263 1169 
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 Value 1171 
 1172 
Sibling Class Relationships 1173 
 List<DVHCurve>  1174 
 1175 
      Parent Class Relationships 1176 
 TreatedPlan 1177 
 1178 
 ImageDataFeature : specific values associated with the image that e.g Radiomics values.  1179 
Every Image has a list of image data features 1180 
 *FeatureName(String) – Need for a standardized list of defined feature names and 1181 
acceptable values  1182 
 Data Type (String): text, number, datetime, bool 1183 
 Value (String) 1184 
 DateOfImageDataFeature (Date) 1185 
 AgeAtImageDataFeature (Decimal F3)  1186 
 1187 
 1188 
Parent Class Relationships 1189 
 Image 1190 
 Patient 1191 
 PatientTreatmentOutcome 1192 
 *DiseaseStatus (String) – Need standardized list e.g. Local Recurrence, NED, 1193 
BiochemicalFailure 1194 
 DateOfStatus (Date) 1195 
 AgeAtStatus (Decimal F3)  1196 
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 DiagnosisAndStaging 1198 
 1199 
Parent Class Relationships 1200 
 Patient 1201 
 Course 1202 
 1203 
 PatientReportedOutcome 1204 
 *SurveyInstrumentName (String) – Need for standardized list 1205 
 *ElementName (String) – Need for standardized list 1206 
 DateOfPRO (Date) 1207 
 AgeAtPRO (Decimal F3)  1208 
 Value (String) 1209 
 ValueType (String) – e.g. Bool, Date, Number 1210 
Sibling Class Relationship 1211 
 Course 1212 
 1213 
Parent Class Relationship 1214 
 Patient 1215 
 1216 
 1217 
 ProviderReportedToxicity 1218 
 *ToxicityName – Use standard names from CTCAE or other standards 1219 
 ToxicityStandard (String) e.g. CTCAE 1220 
 DateOfReportedToxicty (Date) 1221 
 AgeAtReportedToxicity(Decimal F3)  1222 
 Value (String) 1223 
 ValueType (String) – e.g. Bool, Date, Number 1224 
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Sibling Class Relationship 1226 
 Course 1227 
 1228 
Parent Class Relationship 1229 
 Patient 1230 
 1231 
 1232 
 HealthInformation: Used to record data elements relevant to patient status e.g. smoker, rock 1233 
climber, diabetes, etc.  1234 
 *HealthInformationItemName (String) –Need for standardized list  e.g. HasDiabetes, 1235 
IsCurrentSmoker, SmokingPackYears 1236 
 Date (Date) 1237 
 AgeDate (Decimal F3)  1238 
 Value (String) – e.g. True, 20 1239 
 ValueType (String) – Decimal, Bool, Date, String 1240 
               1241 
       Sibling Class Relationships 1242 
 List<Course> 1243 
 1244 
        Parent Class Relationships 1245 
 Patient 1246 
 1247 
 Lab  1248 
 LabName (String) 1249 
 LOINCShortName (String) 1250 
 LOINCCodeName (String) 1251 
 Date (Date) 1252 
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 Value (String) 1254 
 Units (String) 1255 
 ValueType (String) – Decimal, Bool, Date, String 1256 
 1257 
        Sibling Class Relationships 1258 
 Course 1259 
 1260 
        Parent Class Relationships 1261 
 Patient 1262 
 1263 
 Medication  1264 
 MedicationType (String) 1265 
 MedicationName (String) 1266 
 DosageValue (Decimal) 1267 
 DosageUnit (String) 1268 
 Frequency (String) 1269 
 DateOfMedicationRecord 1270 
 AgeAtMedicationRecord (Decimal F3)  1271 
 1272 
        Sibling Class Relationships 1273 
 Course 1274 
 1275 
        Parent Class Relationships 1276 
 Patient 1277 
 1278 
 ChemotherapyCourse: Set of Chemotherapy administrations 1279 
 *Protocol (String) – Need standardized list 1280 
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 Facility (String) 1282 
 IsNeoAdjuvant (Bool) 1283 
 IsConcurrent (Bool) 1284 
 IsAdjuvant (Bool) 1285 
 DateFirstTreatment (Date) 1286 
 AgeAtFirstTreatment (Decimal F3)  1287 
 DateLastTreatment (Date) 1288 
 AgeAtLastTreatment (Decimal F3)  1289 
 1290 
       Sibling Class Relationships 1291 
 Radiation Therapy Course 1292 
 Surgical Procedure 1293 
 1294 
Child Class Relationships 1295 
 List<Chemotherapy Administration> 1296 
 1297 
        Parent Class Relationships 1298 
 Patient 1299 
 DiagnosisAndStaging 1300 
 1301 
 ChemotherapyAdministration 1302 
 Agent (String) 1303 
 Dosage (String) 1304 
 DateOfAdministration (Date) 1305 
 AgeAtAdministration (Decimal F3)  1306 
 1307 
 1308 
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 Facility (String) 1310 
 *Purpose (String) – Need for standardized list 1311 
 *Margins (String) – Need for standardized values 1312 
 *BiopsyStatus (String) – Need for standardized values 1313 
 Is PreIrradiation (Bool) 1314 
 DateOfSurgery (Date) 1315 
 AgeAtSurgery (Decimal F3)  1316 
 1317 
        Sibling Class Relationships 1318 
 Radiation Therapy Course 1319 
 ChemoTherapy Course 1320 
 1321 
       Parent Class Relationships 1322 
 Patient  1323 
 DiagnosisAndStaging 1324 
 1325 
 Pathology 1326 
 *ElementName(String) – Need standardized list 1327 
 *ElementValue (String) 1328 
 *ElementType (String) 1329 
 DateOfPathology (Date) 1330 
 AgeAtPathology (Decimal F3)  1331 
 1332 
        Sibling Class Relationships 1333 
 DiagnosisAndStaging 1334 
 1335 
       Parent Class Relationships 1336 
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 1338 
 1339 
 Charge 1340 
 CPTCode (String) 1341 
 NCodeInstances(Int) 1342 
 DateStartRange (Date) 1343 
 AgeAtStartRange (Decimal F3)  1344 
 DateEndRange (Date) 1345 
 AgeAtEndRange (Decimal F3)  1346 
 1347 
Parent Class Relationships 1348 
 Patient 1349 
 Course 1350 
 1351 
Figure Legend 1352 
Figure 1: The data from RTOG 0012, RTOG 0247, and RTOG 0822 were converted into Resource 1353 
Description Framework (RDF) specifications and were uploaded onto the NRG/IROC/ACR node 1354 
of the Varian learning portal. The mapping was performed according to the diagram shown 1355 
above. Distributed learning is enabled for contracted institutions. The distributed learning 1356 
between this node and another node on the Varian learning portal (MAASTRO Clinic, 1357 
Netherlands) was tested successfully.  1358 
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